Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 68.90
-0.60 (-0.86%)
May 29, 2026, 1:55 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 4.61 billion as of May 29, 2026. Its market cap has increased by 286.70% in one year.
Market Cap
4.61B
Enterprise Value
4.19B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
68.90
Market Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 4.61B, an increase of 105.84%. That is a compound annual growth rate of 38.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 4.61B | 15.14% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 5.65B |
| AnnJi Pharmaceutical | 5.53B |
| Panion & Bf Biotech | 5.19B |
| UnicoCell Biomed | 5.03B |
| ACRO Biomedical | 4.99B |
| Sinew Pharma | 4.86B |
| Medigen Biotechnology | 4.83B |
| Pharmosa Biopharm | 4.76B |